![Food and Drug Administration / Pharmaceuticals policy / Therapeutics / United States Public Health Service / Pharmaceutical industry / Off-label use / Methadone / Prescription Drug User Fee Act / Orphan drug / Pharmacology / Pharmaceutical sciences / Clinical research Food and Drug Administration / Pharmaceuticals policy / Therapeutics / United States Public Health Service / Pharmaceutical industry / Off-label use / Methadone / Prescription Drug User Fee Act / Orphan drug / Pharmacology / Pharmaceutical sciences / Clinical research](https://www.pdfsearch.io/img/6ef1c1d3462617758fae55e312d95700.jpg)
| Document Date: 2014-07-28 12:01:38 Open Document File Size: 241,78 KBShare Result on Facebook
City Washington / DC / Washington / D.C. / / Country United States / / / Facility Rayburn House Office Building / / / IndustryTerm healthcare professional understanding / increased communications / / MedicalCondition rare diseases / disease / rare disease / specific rare diseases / diseases / / Organization Congress / Food and Drug Administration / National Organization for Rare Disorders / U.S. House of Representatives Committee on Energy & Commerce / / Person Peter L. Saltonstall / Diane Dorman / / / Position Chairman / President and CEO / representative / Vice President of Public Policy / / ProgrammingLanguage DC / / Technology drug development / /
SocialTag |